PC
RVNC
Polar Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $28.1M | Sell |
1,115,804
-167,409
| -13% | -$4.21M | 0.21% | 108 |
|
|
2020
Q2 | $31.3M | Buy |
1,283,213
+1,263,279
| +6,337% | +$30.8M | 0.27% | 98 |
|
|
2020
Q1 | $295K | Sell |
19,934
-725,201
| -97% | -$10.7M | ﹤0.01% | 278 |
|
|
2019
Q4 | $12.1M | Buy |
+745,135
| New | +$12.1M | 0.11% | 186 |
|
|
2017
Q4 | – | Sell |
-1,424,213
| Closed | -$39.2M | – | 271 |
|
|
2017
Q3 | $39.2M | Buy |
1,424,213
+127,842
| +10% | +$3.52M | 0.44% | 70 |
|
|
2017
Q2 | $34.2M | Hold |
1,296,371
| – | – | 0.46% | 73 |
|
|
2017
Q1 | $27M | Hold |
1,296,371
| – | – | 0.4% | 84 |
|
|
2016
Q4 | $26.8M | Sell |
1,296,371
-23,500
| -2% | -$486K | 0.43% | 69 |
|
|
2016
Q3 | $21.4M | Buy |
1,319,871
+151,329
| +13% | +$2.45M | 0.37% | 86 |
|
|
2016
Q2 | $15.9M | Sell |
1,168,542
-15,089
| -1% | -$205K | 0.3% | 100 |
|
|
2016
Q1 | $20.7M | Hold |
1,183,631
| – | – | 0.39% | 77 |
|
|
2015
Q4 | $40.4M | Sell |
1,183,631
-899
| -0.1% | -$30.7K | 0.73% | 42 |
|
|
2015
Q3 | $35.2M | Buy |
1,184,530
+54,121
| +5% | +$1.61M | 0.71% | 41 |
|
|
2015
Q2 | $36.2M | Buy |
1,130,409
+23,137
| +2% | +$740K | 0.7% | 42 |
|
|
2015
Q1 | $23M | Hold |
1,107,272
| – | – | 0.43% | 75 |
|
|
2014
Q4 | $18.8M | Buy |
1,107,272
+417,492
| +61% | +$7.07M | 0.37% | 90 |
|
|
2014
Q3 | $13.3M | Buy |
689,780
+112,738
| +20% | +$2.18M | 0.28% | 116 |
|
|
2014
Q2 | $19.6M | Buy |
577,042
+329,589
| +133% | +$11.2M | 0.42% | 85 |
|
|
2014
Q1 | $7.8M | Buy |
+247,453
| New | +$7.8M | 0.18% | 167 |
|